ABBOTT LABORATORIES ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● The company returns high margins, thereby supporting business profitability.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The stock is in a well-established, long-term rising trend above the technical support level at 88.71 USD
Weaknesses
● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● Technically, the stock approaches a strong medium-term resistance at USD 114.42.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● With an enterprise value anticipated at 6.05 times the sales for the current fiscal year, the company turns out to be overvalued.
● With a 2020 P/E ratio at 45.97 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
